NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Zhongping Capital

Zhongping Capital

Shanghai, Shanghaizhongpingcapital.com

Overview

Zhongping Capital is a leading alternative asset manager in China . The firm invests across finance services, TMT, healthcare, environmental services, new energy, and Industry 4.0 . Zhongping aims to create long-term value for its investors by adopting a patient “buy-and-hold” investment approach and helping its portfolio companies achieve their full potential with implementation of growth and best-practice operational strategies . Zhongping Capital incorporates ESG principles into its corporate strategy and the entire investment decision-making process, continuously contributing to the high-quality development of China's economy .

Year Founded

2016

Portfolio Companies

6

Investments

Zhongping Capital investments
CompanyDateStageLead
Cascade Pharmaceuticals, Inc.Feb 2026VC RoundLead
Cascade Pharmaceuticals, Inc.Feb 2026Series CLead
Shanghai Golden Leaf Med Tech Co., Ltd.Mar 2024Series DLead
Xuzhou B&C Chemical Co.,Ltd.Apr 2023VC RoundLead
BluephaFeb 2023Series B ExtensionLead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersShanghai, Shanghai
Year Founded2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.